Advances in the treatment of extranodal NK/T-cell lymphoma, nasal type

M Yamaguchi, R Suzuki… - Blood, The Journal of the …, 2018 - ashpublications.org
Extranodal natural killer/T-cell lymphoma, nasal type (ENKL) is a subtype of mature T-and
natural killer cell lymphomas characterized by its association with Epstein-Barr virus and …

Extranodal NK/T cell lymphoma, nasal type (ENKTL-NT): an update on epidemiology, clinical presentation, and natural history in North American and European cases

BM Haverkos, Z Pan, AA Gru, AG Freud… - Current hematologic …, 2016 - Springer
Abstract Purpose of Review Extranodal NK/T cell lymphoma, nasal type (ENKTL-NT) is an
aggressive extranodal non-Hodgkin lymphoma most commonly occurring in East Asia and …

Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a …

A Jaccard, N Gachard, B Marin, S Rogez… - Blood, The Journal …, 2011 - ashpublications.org
Extranodal NK/T-cell lymphoma, nasal type, is a rare and highly aggressive disease with a
grim prognosis. No therapeutic strategy is currently identified in relapsing patients. We report …

Nutrition and carcinogenesis

AR Collins, LR Ferguson - Mutation Research/Fundamental and Molecular …, 2004 - Elsevier
Traditional views of nutritional carcinogenesis depend on the identification of exogenous
carcinogens as major risk factors. As our understanding evolves, it is clear that the pattern of …

Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211

M Yamaguchi, K Tobinai, M Oguchi… - Journal of clinical …, 2009 - ascopubs.org
Purpose To explore a more effective treatment for localized nasal natural killer (NK)/T-cell
lymphoma, we conducted a phase I/II study of concurrent chemoradiotherapy. Patients and …

Risk-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma: analysis from a multicenter study

Y Yang, Y Zhu, JZ Cao, YJ Zhang… - Blood, The Journal …, 2015 - ashpublications.org
The optimal combination and sequence of radiotherapy (RT) and chemotherapy (CT) for
extranodal nasal-type natural killer/T-cell lymphoma (NKTCL) are not well-defined. The aim …

Treatments and outcomes of patients with extranodal natural killer/T-cell lymphoma diagnosed between 2000 and 2013: a cooperative study in Japan

M Yamaguchi, R Suzuki, M Oguchi, N Asano… - Journal of Clinical …, 2017 - ascopubs.org
Purpose To elucidate the management and outcomes of patients with extranodal natural
killer/T-cell lymphoma, nasal type (ENKL), who were diagnosed between 2000 and 2013 in …

A critical review on properties and applications of microbial l-asparaginases

PR Krishnapura, PD Belur… - Critical reviews in …, 2016 - Taylor & Francis
Abstract l-Asparaginase is one of the main drugs used in the treatment of acute
lymphoblastic leukemia (ALL), a commonly diagnosed pediatric cancer. Although several …

Guidelines for the management of mature T‐cell and NK‐cell neoplasms (excluding cutaneous T‐cell lymphoma)

CE Dearden, R Johnson, R Pettengell… - British journal of …, 2011 - Wiley Online Library
The peripheral T‐cell neoplasms are a biologically and clinically heterogeneous group of
rare disorders that result from clonal proliferation of mature post‐thymic lymphocytes …

[HTML][HTML] Molecular analysis of L-asparaginases for clarification of the mechanism of action and optimization of pharmacological functions

MV Pokrovskaya, VS Pokrovsky, SS Aleksandrova… - Pharmaceutics, 2022 - mdpi.com
L-asparaginases (EC 3.5. 1.1) are a family of enzymes that catalyze the hydrolysis of L-
asparagine to L-aspartic acid and ammonia. These proteins with different biochemical …